LDH in Chronic (Indolent) Mantle Cell Lymphoma
LDH is typically normal in chronic/indolent mantle cell lymphoma, and normal LDH is actually one of the defining features that helps identify this indolent subtype.
Key Diagnostic Features of Indolent MCL
The indolent or "leukaemic non-nodal" subtype of MCL presents with distinctly different laboratory findings compared to aggressive MCL:
- Normal serum LDH levels are characteristic of indolent MCL presentations 1
- Normal β2-microglobulin levels also accompany the indolent form 1
- These patients typically have low MIPI (MCL International Prognostic Index) scores, which incorporate LDH as one of the prognostic factors 2
Clinical Context and Risk Stratification
Elevated LDH is a marker of aggressive disease and high-risk features:
- Elevated LDH is specifically listed as a risk factor for CNS involvement in MCL, along with blastoid variant and impaired performance status 2
- The MIPI prognostic model incorporates LDH as one of four key variables (along with ECOG performance status, age, and leukocyte count) to stratify risk 3, 4
- In the relapsed/refractory setting, elevated LDH at progression is associated with inferior overall survival 5
Distinguishing Indolent from Aggressive MCL
Additional features that accompany normal LDH in indolent presentations include:
- Leukaemic non-nodal presentation with bone marrow involvement and splenomegaly 2
- SOX11 negativity 2
- Low Ki-67 (<10-30%) 1, 4
- Maximum tumor diameter <3 cm 1
- Absence of B symptoms 1
- Normal CBC at presentation 6
Clinical Implications
The presence of normal LDH supports a "watch and wait" approach in selected cases: